Metabolic phenotypes of early gestational diabetes mellitus and their association with adverse pregnancy outcomes
- PMID: 32991758
- DOI: 10.1111/dme.14413
Metabolic phenotypes of early gestational diabetes mellitus and their association with adverse pregnancy outcomes
Abstract
Aims: To describe the metabolic phenotypes of early gestational diabetes mellitus and their association with adverse pregnancy outcomes.
Methods: We performed a post hoc analysis using data from the Vitamin D And Lifestyle Intervention for gestational diabetes prevention (DALI) trial conducted across nine European countries (2012-2014). In women with a BMI ≥29 kg/m2 , insulin resistance and secretion were estimated from the oral glucose tolerance test values performed before 20 weeks, using homeostatic model assessment of insulin resistance and Stumvoll first-phase indices, respectively. Women with early gestational diabetes, defined by the International Association of Diabetes and Pregnancy Study Groups criteria, were classified into three groups: GDM-R (above-median insulin resistance alone), GDM-S (below-median insulin secretion alone), and GDM-B (combination of both) and the few remaining women were excluded.
Results: Compared with women in the normal glucose tolerance group (n = 651), women in the GDM-R group (n = 143) had higher fasting and post-load glucose values and insulin levels, with a greater risk of having large-for-gestational age babies [adjusted odds ratio 3.30 (95% CI 1.50-7.50)] and caesarean section [adjusted odds ratio 2.30 (95% CI 1.20-4.40)]. Women in the GDM-S (n = 37) and GDM-B (n = 56) groups had comparable pregnancy outcomes with those in the normal glucose tolerance group.
Conclusions: In overweight and obese women with early gestational diabetes, higher degree of insulin resistance alone was more likely to be associated with adverse pregnancy outcomes than lower insulin secretion alone or a combination of both.
© 2020 Diabetes UK.
References
REFERENCES
-
- World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy, WHO/NMH/MND/ 13.2. Geneva: World health Organization. 2013. Available at http://apps.who.int/iris/bitstream/10665/85975/1/WHO_NMH_MND_13.2_eng.pdf. Last accessed 10 January 2019.
-
- Kautzky-Willer A, Prager R, Waldhausl W, et al. Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy. Diabetes Care. 1997;20:1717-1723.
-
- Ryan EA, O’Sullivan MJ, Skyler JS. Insulin action during pregnancy: studies with euglycemic clamp technique. Diabetes. 1985;34:380-389.
-
- Ellard S, Beards F, Allen LL, et al. A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia. 2000;43:250-253.
-
- Catalano PM, Tyzbir ED, Sims EA. Incidence and significance of islet cell antibodies in women with previous gestational diabetes. Diabetes Care. 1990;13:478-482.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
